Nuora / Requested page
Nuora is waiting for the requested page to respond.
Menopause Support
Internal proof mode
Structured symptom tracking and care-model review under pharmacist oversight. This pathway is currently proof-mode only and not available for patient launch.
Internal evaluation · No patient pathway open
Internal evaluation
Governance review
No patient intake
No treatment offered
Proof governance
Structured symptom tracking and care-model review under pharmacist oversight. This pathway is currently proof-mode only and not available for patient launch.
Governance model under reviewThese rows describe internal design inputs, not an available patient service.
Internal governance areas under review; no patient pathway is open.
Internal validation of non-hormonal support governance before any patient-facing service opens.
Digital logging of vasomotor symptoms, sleep quality, mood, and menstrual patterns.
Evidence-based advice on exercise, nutrition, and complementary approaches.
Assessment of osteoporosis risk factors and referral for DEXA scan if indicated.
Structured approaches to managing anxiety, low mood, and sleep disturbance during perimenopause.
Scheduled pharmacist consultations to review symptom burden and treatment response.
Internal review sequence
These stages describe the model being evaluated. No intake, treatment or follow-up pathway is open.
Assessment model
Model under review — Complete a menopause symptom assessment covering hot flushes, sleep, mood, and current medications.
Review model
Model under review — A pharmacist reviews your symptoms and medical history to determine appropriate treatment options.
Governance
Model under review — Internal review checks how lifestyle support, onward referral, and pharmacist oversight should be governed before any public pathway opens.
Follow-up model
Model under review — Continuous symptom-score tracking with regular pharmacist review and treatment adjustments.
Criteria under review
These source criteria are not an open eligibility screen and do not begin patient care.
Internal evaluation only. No patient pathway is open.
Women or people assigned female at birth, typically aged 40 and over
Experiencing perimenopause or menopause symptoms
No current breast cancer or hormone-sensitive cancer history (for hormonal options)
No undiagnosed vaginal bleeding
Willing to engage with regular symptom tracking and clinical reviews
Internal proof mode
We are validating the pharmacist-review model internally before any public patient pathway opens.
This internal proof route does not accept patient intake or registration.
